Loading
Total declarations
Companies
▲ Purchases (18 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Aug 2016 for VivoSim Labs, INC..
Insider track record
Disclosed buys
18
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
18
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +70.0%Entry US$648.00 · Close at T+365 US$1,101.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
James T. Glover: trading record in brief
Filings by James T. Glover span 4 companies, the busiest being Anadys Pharmaceuticals Inc, Varian Inc and Beckman Coulter Inc. Between 5 January 2006 and 17 August 2016, the trades on record add up to 23 filings.
No open-market sale appears; the market trades are 18 purchases worth €99k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 4 share grants.
In size, the median ticket on the buying side is €3,140.
The newest entry dates from 19 August 2016: a share grant, in VivoSim Labs, Inc. The last purchase on record was published on 13 August 2015, which is 4,089 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James T. Glover
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
7,500 shares0Common StockSEC:0001209191-16-138009:0
10,000 shares@ US$2.80Common StockSEC:0001209191-15-065924:0
Canonical exit: 11 Nov 2015 (T+90)
1,000 shares@ US$52.00Common StockSEC:0001079028-10-000017:0
100 shares@ US$48.98Common StockSEC:0001079028-08-000039:0
Canonical exit: 28 Oct 2008 (T+90)
100 shares@ US$48.97Common StockSEC:0001079028-08-000039:1
Canonical exit: 28 Oct 2008 (T+90)
100 shares@ US$48.96Common StockSEC:0001079028-08-000039:2
Canonical exit: 28 Oct 2008 (T+90)
600 shares@ US$48.95Common StockSEC:0001079028-08-000039:3
Canonical exit: 28 Oct 2008 (T+90)
100 shares@ US$48.99Common StockSEC:0001079028-08-000039:4
Canonical exit: 28 Oct 2008 (T+90)
1,000 shares@ US$2.10Common StockSEC:0001209191-07-064949:0
Canonical exit: 13 Feb 2008 (T+90)
200 shares@ US$2.05Common StockSEC:0001209191-07-064949:1
Canonical exit: 13 Feb 2008 (T+90)
600 shares@ US$2.00Common StockSEC:0001209191-07-064949:2
Canonical exit: 14 Feb 2008 (T+90)
1,599 shares@ US$2.10Common StockSEC:0001209191-07-063472:0
Canonical exit: 6 Feb 2008 (T+90)
3,401 shares@ US$2.10Common StockSEC:0001209191-07-063472:1
Canonical exit: 7 Feb 2008 (T+90)
1,000 shares@ US$2.17Common StockSEC:0001209191-07-048665:0
Canonical exit: 13 Nov 2007 (T+90)
3,170 shares@ US$3.45Common StockSEC:0001209191-07-015126:0
Canonical exit: 29 May 2007 (T+90)
1,000 shares@ US$3.45Common StockSEC:0001209191-07-015126:1
Canonical exit: 29 May 2007 (T+90)
2,200 shares@ US$4.60Common StockSEC:0001209191-06-064380:0
Canonical exit: 11 Mar 2007 (T+90)
1,788 shares@ US$51.38Common StockSEC:0000840467-06-000089:1
2,500 shares0Common StockSEC:0000840467-06-000024:0
19 of 19 declarations
